Leadership Team
An executive team with strong expertise in metabolism and diabetes, in clinical developments, as well as in biopharmaceutical business
Dr. Laure Jamot, PhD
COO/CSO
Dr. Jamot has a PhD and spent her professionnal carrer in biotech companies. She is former head of preclinical and clinical R&D and former head of IP. She has strong successful expertise in clinical trials by conducting 16 clinical trials
Pr. Christophe Magnan, PhD
Head of the Research Lab
Prof. Christophe Magnan is professor at the University of Paris. He is an expert in glucose homeostasis and signed more than 150 scientific papers. He is head of REGLYS within UMR 8251, with which THAC collaborates to complete the preclinical studies.
Scientific Consultants
Dr. Aurélie Joly-Amado, PHD
Research scientist University of South Florida
Consultant on neurodegenerative diseases
Dr. Céline Cruciani-Guglielmacci, PhD
Professor University Paris Cité
Consultant on Metabolic syndrome and diabetes
The CSIS is reporting to the President of the French Republics, to the Prime Minister as well as to the three Ministers for Industry, Health and Research.
